LBX Pharmacy Chain JSC (SHSE:603883) PE Ratio without NRI: 15.73 (As of Jul. 19, 2026) — 49% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603883 LBX Pharmacy Chain JSC SHSE:603883
80 GF Score
Price ¥12.27
GF Value ¥19.22
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is LBX Pharmacy Chain JSC PE Ratio without NRI?

LBX Pharmacy Chain JSC SHSE:603883 -1.84% 80 PE Ratio without NRI is 15.73 as of Jul. 19, 2026, which is 49% below its 10-year median of 30.79. GuruFocus rates SHSE:603883 with a GF Score™ of 80/100 and a GF Value™ of ¥19.22 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 440 Healthcare Providers & Services companies, LBX Pharmacy Chain JSC ranks better than 63.86% on this metric.

The PE Ratio without NRI, or P/E Ratio without non-recurring items, is a financial ratio used to compare a company's market price to its EPS without NRI. As of today (2026-07-19), LBX Pharmacy Chain JSC's share price is ¥12.27. LBX Pharmacy Chain JSC's EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 was ¥0.78. Therefore, LBX Pharmacy Chain JSC's PE Ratio without NRI for today is 15.73.

During the past 13 years, LBX Pharmacy Chain JSC's highest PE Ratio without NRI was 60.44. The lowest was 9.96. And the median was 30.79.

LBX Pharmacy Chain JSC's EPS without NRI for the three months ended in Mar. 2026 was ¥0.35. Its EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 was ¥0.78.

As of today (2026-07-19), LBX Pharmacy Chain JSC's share price is ¥12.27. LBX Pharmacy Chain JSC's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ¥0.52. Therefore, LBX Pharmacy Chain JSC's PE Ratio (TTM) for today is 23.60.

During the past years, LBX Pharmacy Chain JSC's highest PE Ratio (TTM) was 61.95. The lowest was 10.18. And the median was 33.41.

LBX Pharmacy Chain JSC's EPS (Diluted) for the three months ended in Mar. 2026 was ¥0.35. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ¥0.52.

LBX Pharmacy Chain JSC's EPS (Basic) for the three months ended in Mar. 2026 was ¥0.35. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was ¥0.52.


LBX Pharmacy Chain JSC  (SHSE:603883) PE Ratio without NRI Explanation

The PE Ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio is positive. Also for stocks with the same PE Ratio, the one with faster growth business is more attractive.

If a company loses money, the PE Ratio becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio divided by the growth ratio. He thinks a company with a PE Ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio of 20, instead of a company growing 10% a year with a PE Ratio of 10.

Because the PE Ratio measures how long it takes to earn back the price you pay, the PE Ratio can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio without NRI measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratio s are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio.


LBX Pharmacy Chain JSC PE Ratio without NRI Related Terms


LBX Pharmacy Chain JSC PE Ratio without NRI Historical Data

* Premium members only.

The historical data trend for LBX Pharmacy Chain JSC's PE Ratio without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LBX Pharmacy Chain JSC PE Ratio without NRI Chart

LBX Pharmacy Chain JSC Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
PE Ratio without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only 35.29 31.86 20.62 25.18 32.17

LBX Pharmacy Chain JSC Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
PE Ratio without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 25.72 31.93 24.57 32.17 17.35

LBX Pharmacy Chain JSC PE Ratio without NRI Competitor Comparison

For the Pharmaceutical Retailers subindustry, LBX Pharmacy Chain JSC's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LBX Pharmacy Chain JSC PE Ratio without NRI vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, LBX Pharmacy Chain JSC's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where LBX Pharmacy Chain JSC's PE Ratio without NRI falls into.


SHSE:603883
80GF Score
LBX Pharmacy Chain JSC SHSE:603883
PE Ratio without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

LBX Pharmacy Chain JSC PE Ratio without NRI Calculation

The PE Ratio without NRI, or P/E Ratio without non-recurring items, is a financial ratio used to compare a company's market price to its EPS without NRI. Regular PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than regular PE Ratio.

LBX Pharmacy Chain JSC's PE Ratio without NRI for today is calculated as

PE Ratio without NRI=Share Price/ EPS without NRI
=12.27/0.780
=15.73

LBX Pharmacy Chain JSC's Share Price of today is ¥12.27.
LBX Pharmacy Chain JSC's EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.78.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

There are at least three kinds of PE Ratios used by different investors. They are Trailing Twelve Month PE Ratio, Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio based on inflation-adjusted normalized PE Ratio is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

In the calculation of PE Ratio (TTM), the earnings per share used are the earnings per share over the past 12 months.

For Forward PE Ratio, the earnings are the expected earnings for the next twelve months.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.

Frequently Asked Questions Learn more about PE Ratio without NRI →
What does a PE Ratio without NRI of 15.73 mean?
LBX Pharmacy Chain JSC (SHSE:603883) has a PE Ratio without NRI of 15.73 as of Jul. 19, 2026. P/E without nonrecurring items is the ratio of share price to a company's earnings less one-time charges. View historical data on LBX Pharmacy Chain JSC and its competitors. This is 49% below median its historical median of 30.79. Over the past decade, LBX Pharmacy Chain JSC's PE Ratio without NRI has ranged from 9.96 to 60.44. According to the industry distribution chart, LBX Pharmacy Chain JSC ranks #159 out of 440 companies in the Healthcare Providers & Services industry, placing it in the top 36.1%.
Is LBX Pharmacy Chain JSC's PE Ratio without NRI too high?
LBX Pharmacy Chain JSC's current PE Ratio without NRI of 15.73 is 49% below median its 10-year median of 30.79. Over the past 10 years, this metric has ranged from a low of 9.96 to a high of 60.44. The Healthcare Providers & Services industry median PE Ratio without NRI is 20.08. LBX Pharmacy Chain JSC's value of 15.73 is 21.7% below this industry median. Based on the distribution chart, LBX Pharmacy Chain JSC ranks #159 out of 440 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, LBX Pharmacy Chain JSC has a GF Score™ of 80/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does LBX Pharmacy Chain JSC's PE Ratio without NRI compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, LBX Pharmacy Chain JSC ranks #159 out of 440 companies for PE Ratio without NRI. This puts LBX Pharmacy Chain JSC in the upper half of its industry. The industry median PE Ratio without NRI is 20.08. LBX Pharmacy Chain JSC's value of 15.73 is 21.7% below this benchmark. Historically, LBX Pharmacy Chain JSC's own PE Ratio without NRI has ranged from 9.96 to 60.44 over the past decade. While the company's 10-year median is 30.79 vs. the industry median of 20.08, LBX Pharmacy Chain JSC has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PE Ratio without NRI for a Healthcare Providers & Services company?
The median PE Ratio without NRI among Healthcare Providers & Services companies is 20.08, based on 440 companies in the industry. Companies in the top quartile (top 25%) have a PE Ratio without NRI significantly above this median, while those in the bottom quartile fall well below. However, PE Ratio without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. LBX Pharmacy Chain JSC's current PE Ratio without NRI of 15.73 is 21.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PE Ratio without NRI mean?
A high PE Ratio without NRI can signal that a stock is expensive relative to its fundamentals. P/E without nonrecurring items is the ratio of share price to a company's earnings less one-time charges. View historical data on LBX Pharmacy Chain JSC and its competitors. For the Healthcare Providers & Services industry, the median PE Ratio without NRI is 20.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. LBX Pharmacy Chain JSC's current PE Ratio without NRI is 15.73, which is 49% below median its own 10-year median of 30.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LBX Pharmacy Chain JSC stock overvalued right now?
Based on GuruFocus' analysis, LBX Pharmacy Chain JSC (SHSE:603883) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥19.22, compared to a current price of ¥12.27 — trading 36.2% below its estimated fair value. The current PE Ratio without NRI is 15.73, which is 49% below median its 10-year median of 30.79 and 21.7% below the Healthcare Providers & Services industry median of 20.08. LBX Pharmacy Chain JSC's overall GF Score™ is 80/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PE Ratio without NRI calculated?
PE Ratio without NRI is calculated from a company's financial statements. For LBX Pharmacy Chain JSC (SHSE:603883), the current PE Ratio without NRI is 15.73 as of Jul. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is LBX Pharmacy Chain JSC (SHSE:603883) Overvalued in 2026?

Based on GuruFocus' analysis, LBX Pharmacy Chain JSC stock appears to be undervalued. The current stock price of ¥12.27 is trading 36.2% below its estimated GF Value™ of ¥19.22. GuruFocus considers LBX Pharmacy Chain JSC to be Significantly Undervalued.

Key valuation signals for SHSE:603883:

  • PE Ratio without NRI: 15.73 (49% below median its 10-year median of 30.79)
  • GF Value™: ¥19.22 vs. price of ¥12.27 (36.2% below fair value)
  • GF Score™: 80/100 with 4 warning signs
  • Industry Position: 21.7% below the Healthcare Providers & Services median (#159 of 440)

No single metric tells the full story. See the SHSE:603883 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


LBX Pharmacy Chain JSC Business Description

Address No. 288, Xiangya Road, Kaifu District, Hunan, Changsha, CHN, 410005
LBX Pharmacy Chain JSC is a China-based company engages in the sale of medicine and health products. The company is engaged in retailing drugs and other related products, including Chinese and Western medicine, prepared slices of Chinese crude drugs, health equipment, healthy food, and personal care products and life care products. The company is also involved in the wholesale and manufacture of drugs.
80GF Score

Get the complete analysis for SHSE:603883

PE Ratio without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥12.27
Price
¥19.22
GF Value